ADMA Biologics
ADMA
$6.81
Share price
1.04%
Change (1 day)
99.12%
Change (1 year)
Categories
ADMA Biologics (ADMA) - Total debt
Total debt on the balance sheet as of December 2023 : $0.14 B
According to ADMA Biologics 's latest financial reports the company's total debt is $0.14 B. A company’s total debt is the sum of all current and non-current debts.
ADMA Biologics - Total debt on balance sheet (from 2012 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.14 B | -8.43% |
| 2022-12-31 | $0.15 B | 50.06% |
| 2021-12-31 | $0.10 B | 5.38% |
| 2020-12-31 | $97.66 M | 15.27% |
| 2019-12-31 | $84.73 M | 91.59% |
| 2018-12-31 | $44.22 M | 2.92% |
| 2017-12-31 | $42.97 M | 112.49% |
| 2016-12-31 | $20.22 M | 28.56% |
| 2015-12-31 | $15.73 M | 6.53% |
| 2014-12-31 | $14.76 M | 190.92% |
| 2013-12-31 | $5.07 M | 27.88% |
| 2012-12-31 | $3.96 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | $0.71 B | 403.33% | 🇺🇸 USA |
 Novavax NVAX | $0.22 B | 61.99% | 🇺🇸 USA |
 Cel-Sci
CVM | $13.09 M | -90.74% | 🇺🇸 USA |